Home›Stock Screener›Zenotech Laboratories

Zenotech Laboratories Share Price Today | Stock Price & Zenotech Laboratories Share Screener

ZENOTECH Pharmaceuticals
Live Share Price BSE
₹42.13
▲ 0.14 (0.33%)
2026-10-05 00:00:00

As of October 5, 2026, the live Zenotech Laboratories share price (BSE: ZENOTECH) is ₹42.13, up 0.33% from the previous close, with shares trading between ₹41.00 and ₹44.00 in today's trading session, and a 52-week range of ₹34.29–₹53.49. Check Zenotech Laboratories 52-week for the annual price range and momentum. Use the Zenotech Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Zenotech Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹6 and net income of ₹1, with EBITDA of ₹2, an operating margin of 24.0% and a profit margin of 16.7%.

Zenotech Laboratories Market Cap ₹256.97 Cr.
ZENOTECH P/E Ratio (TTM) -
Zenotech Laboratories P/B Ratio 2.69
EPS (TTM) ₹-0.18
Dividend Yield -
Debt to Equity -
ZENOTECH 52 Week High ₹53.49
Zenotech Laboratories 52 Week Low ₹34.29
Operating Margin 24.00%
Profit Margin 16.67%
ZENOTECH Revenue (TTM) ₹6.00
EBITDA ₹2.00
Net Income ₹1.00
Total Assets ₹111.00
Total Equity ₹95.00

Zenotech Laboratories Share Price Chart

Track the current stock price of Zenotech Laboratories with an interactive chart. Analyse ZENOTECH share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Zenotech Laboratories stock quote in one place.

The quote of ₹42.13 sits between the 52-week low of ₹34.29 and the 52-week high of ₹53.49, and the latest session moved 0.33% from the previous close.

Zenotech Laboratories Company Profile - Fundamental Screener

Screen Zenotech Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ZENOTECH shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE486F01012.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE486F01012

Zenotech Laboratories Balance Sheet Screener

Screen ZENOTECH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹111, down from ₹111 in 2025.

Latest statistics put total assets at ₹111 and shareholder funds at ₹95.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 111 111 106 101 94 86 86 85 82 51
Current Assets 41 36 26 16 7 7 6 19 31 2
Fixed Assets 62 61 66 65 71 74 49 43 44 47

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 4 2 2 2 8 23 1 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 95 96 91 82 71 48 50 39 42 -66
Share Capital 61 61 61 61 61 61 61 61 61 34
Reserves & Surplus 34 35 30 21 10 -13 -11 -22 -19 -100

Zenotech Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Zenotech Laboratories income statement and profit fundamentals. Analyze ZENOTECH quarterly results. Zenotech Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2006-Sept, revenue was ₹6 and net profit was ₹1, at an operating margin of 24%.

In that period expenses were ₹4, interest cost ₹0 and tax ₹0. The next period listed, 2006-Jun, shows revenue of ₹3 and net profit of ₹-2.

Item 2006-Sept 2006-Jun

Revenue and Expenses

Revenue 6 3
Expenses 4 4

Operating Costs and Margins

EBITDA 2 -1
Operating Profit % 24.00% -52.00%
Depreciation 0 0
Interest 0 0

Profit and Earnings

Profit Before Tax 1 -2
Tax 0 0
Net Profit 1 -2
EPS 0.00 0.00

Zenotech Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen ZENOTECH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹10, and net cash flow was an inflow of ₹4.

Over the same period, investing activities used ₹7 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 10 10 12 21 18 6 11 -14 -16 2
Investing Activities -7 15 -21 -6 -2 -5 -21 -16 -3 -1

Financing and Net Cash

Financing Activities 0 0 0 -6 -16 0 -3 15 47 -1
Net Cash Flow 4 25 -9 9 0 1 -12 -15 28 0

Zenotech Laboratories Shareholding Pattern Screener

See Zenotech Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Zenotech Laboratories promoter holding and ownership changes for ZENOTECH on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 68.84%, foreign institutions 0.00%, domestic institutions 0.01% and the public 22.81%, spread across 10,161 shareholders.

The shareholder count was 10,161 in 2026-Jun, compared with 10,301 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept

Promoter Holding

Promoter Holding 68.84% 68.84% 68.84% 68.84% 68.84% 68.84% 68.84% 68.84%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

Government, Public and Others

Govt Holding 0.98% 0.98% 0.98% 0.98% 0.98% 0.98% 0.98% 0.98%
Public Holding 22.81% 22.81% 22.78% 22.80% 22.78% 22.78% 22.83% 22.66%
Other Holding 7.36% 7.35% 7.38% 7.36% 7.38% 7.39% 7.34% 7.51%
Shareholder Count 10,161 10,301 10,464 10,670 10,661 10,690 10,667 10,641

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Zenotech Laboratories. Zenotech Laboratories dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Zenotech Laboratories.

Zenotech Laboratories Stock Index Membership - Nifty & Sensex

See which indices include Zenotech Laboratories stock. Check ZENOTECH index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Zenotech Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

Zenotech Laboratories Market Events Screener - Corporate Actions

Get Zenotech Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Zenotech Laboratories stock events that may affect ZENOTECH share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 25, 2026, with a record date of September 25, 2026.

It is followed by Quarterly Result Announcement dated July 28, 2026 and Quarterly Result Announcement dated April 29, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-25 2026-09-25 Annual General Meeting NA -3.53%
2026-07-28 2026-07-28 Quarterly Result Announcement NA 1.14%
2026-04-29 2026-04-29 Quarterly Result Announcement NA -3.34%
2026-01-23 2026-01-23 Quarterly Result Announcement NA 0.56%
2025-10-31 2025-10-31 Quarterly Result Announcement NA 6.75%
2025-09-26 2025-09-26 Annual General Meeting NA -14.96%
2025-07-28 2025-07-28 Quarterly Result Announcement NA -0.16%
2025-04-25 2025-04-25 Quarterly Result Announcement NA -0.59%
2025-01-28 2025-01-28 Quarterly Result Announcement NA -5.92%
2024-10-23 2024-10-23 Quarterly Result Announcement NA -8.89%
2024-09-27 2024-09-27 Annual General Meeting NA 44.66%
2023-09-29 2023-09-29 Annual General Meeting NA 2.60%
2017-06-01 2017-06-02 Rights 17:22 -

Zenotech Laboratories Competitors Screener - Peer Stocks Comparison

Screen ZENOTECH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 427,010 35.84 61,674 12.69% 11,565 33.78
Divis Laboratories 244,125 84.36 11,067 13.95% 2,568 49.73
Torrent Pharmaceuticals 181,512 84.01 13,886 20.34% 2,138 41.48
Zydus Life Science 113,616 24.88 27,658 17.64% 5,026 46.18
Cipla 107,890 32.42 29,045 2.24% 3,870 32.87
Laurus Labs 106,517 98.56 6,868 22.01% 890 56.11
Mankind Pharma 102,394 50.48 14,636 14.85% 1,938 55.53
Dr Reddys Laboratories 100,412 31.47 35,059 3.90% 4,158 52.91
Aurobindo Pharma 96,370 25.97 34,145 5.56% 3,503 49.89
Lupin 91,961 16.71 29,039 26.75% 5,356 29.12

Zenotech Laboratories Company Announcements - News & Reports Screener

Screen ZENOTECH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 28, 2026.

The next most recent announcements are dated September 28, 2026 and September 27, 2026.

Date Update Actions
2026-09-28 Closure of Trading Window -
2026-09-28 Voting Results And Scrutinizer Report Of 37Th Annual General Meeting Held On September 25 2026 -
2026-09-27 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-29 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-28 Notice Of 37Th Annual General Meeting To Be Held On Friday September 25 2026 Along With Annual Report For The FY 2025-26. -
2026-08-28 Reg. 34 (1) Annual Report. -
2026-08-24 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-22 Intimation Of 37Th Annual General Meeting Of Zenotech Laboratories Limited -
2026-07-29 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-07-28 Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. July 28 2026 -
2026-07-28 Unaudited Financial Results For The Quarter Ended June 30 2026 -
2026-07-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-13 Board Meeting Intimation for Considering And Approving Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30 2026. -
2026-06-30 Closure of Trading Window -
2026-05-27 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-04-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-04-29 Audited Standalone Financial Results For The Quarter And Financial Year Ended March 31 2026 -
2026-04-29 Board Meeting Outcome for Outcome Of The Board Meeting Held On April 29 2026 -
2026-04-28 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-23 Board Meeting Intimation for Considering And Approving Audited Standalone Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹42.13, within a 52-week range of ₹34.29 to ₹53.49. The P/B ratio is 2.69. Market capitalisation stands at ₹256.97 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on October 7, 2026. This page covers 10 balance sheet periods, 2 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.